Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam ...
A technique borrowed from radiation oncology that takes the catheter out of catheter ablation continued to put in an impressive performance, observers say, in the longest yet follow-up of patients ...
In a "strong statements and controversies" session at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2017 meeting, Prof Gerhard Hindricks (University of Leipzig, Germany) said ...
TipRanks on MSN
Imricor Achieves Milestone with First MRI-Guided VT Ablation
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) just unveiled an announcement. Imricor Medical Systems, Inc. announced a significant milestone in the field of ...
Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...
NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
In a finding that may improve the safety of an increasingly common procedure, use of direct oral anticoagulants (DOACs) instead of aspirin after radiofrequency ablation for ventricular tachycardia or ...
A percentage of patients with scar-related ventricular tachycardia who underwent radiofrequency catheter ablation experienced early mortality, which may have been predicted by procedural and clinical ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an ...
Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results